Lilly and Novo Nordisk are refunding 340B covered entities on some products due to 340B ceiling price adjustments.
Lilly and Novo Post 340B Refund Notices, Amgen Posts 340B Replenishment Notice
Drugmakers Lilly and Novo Nordisk are giving covered entities refunds on some products due to 340B ceiling price adjustments, according [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.